SUNNYVALE, Calif., July 31, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, today announced that it will report results for its fourth quarter and fiscal year 2012, ended June 30, 2012 on Thursday, September 6, 2012 after the market closes.
A conference call to review the results will begin at 2:00 p.m. PDT/5:00 p.m. EDT and will be hosted by Euan S. Thomson, Ph.D., president and chief executive officer and Derek Bertocci, senior vice president and chief financial officer.
The conference call dial-in numbers are 1-800-295-4740 (USA) or 1-617-614-3925 (International), Conference ID: 89497327. In addition, a dial-up replay of the conference call will be available beginning September 6, 2012 at 5:00 p.m. PDT/8:00 p.m. EDT and ending on September 13, 2012. The replay telephone number is 1-888-286-8010 (USA) or 1-617-801-6888 (International), Conference ID: 79000863.
A live webcast of the call will also be available from the Investor Relations section of the corporate website at http://www.accuray.com/investors. A webcast replay can be accessed on the corporate website beginning Thursday, September 6, 2012 at approximately 5:00 p.m. PDT/8:00 p.m. EDT. The replay will remain available until Accuray announces its results for the first quarter of fiscal 2013, ending September 30, 2012.
About Accuray
Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is the premier radiation oncology company that develops, manufactures and sells personalized innovative treatment solutions that set the standard of care, with the aim of helping patients live longer, better lives. The Company's leading edge technologies – the CyberKnife and TomoTherapy Systems – are designed to deliver radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image guided radiation therapy, and adaptive radiation therapy. To date, more than 635 systems have been installed in leading hospitals around the world. For more information, please visit www.accuray.com.
SOURCE Accuray Incorporated